# CRISPR Therapeutics AG: filings

CRSP · Nasdaq · CIK 1674416 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crsp.md) · [Financials](/companies/crsp/financials.md) · [Filings](/companies/crsp/filings.md) · [Insiders](/companies/crsp/insiders.md)

## Reports and events: 204 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 450, 8-K 135, 3 34, 10-Q 30, SC 13G/A 23, 144 20, 424B5 17, DEFA14A 12, SC 13D/A 12, UPLOAD 11, 10-K 10, DEF 14A 10, PRE 14A 10, SCHEDULE 13G/A 10, S-8 9, CORRESP 8, 4/A 7, SC 13G 7, DRS/A 5, ARS 4, CT ORDER 4, SC 13D 4, 3/A 3, S-3ASR 3, D 2, EFFECT 2, PRER14A 2, S-1/A 2, SCHEDULE 13G 2, 424B4 1, 8-A12B 1, CERTNAS 1, D/A 1, DRS 1, DRSLTR 1, S-1 1, S-3 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 16:11 ET | [8-K](/filings/0001193125-26-425243.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-425243 |
| 2026-08-03 | 16:31 ET | [10-Q](/filings/0001193125-26-330672.md) | Quarterly report, period 2026-06-30 | 0001193125-26-330672 |
| 2026-08-03 | 16:24 ET | [8-K](/filings/0001193125-26-330644.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-330644 |
| 2026-06-04 | 16:45 ET | [8-K](/filings/0001193125-26-257593.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257593 |
| 2026-05-04 | 16:48 ET | [10-Q](/filings/0001193125-26-204188.md) | Quarterly report, period 2026-03-31 | 0001193125-26-204188 |
| 2026-05-04 | 16:41 ET | [8-K](/filings/0001193125-26-204147.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204147 |
| 2026-04-21 | 08:05 ET | [DEF 14A](/filings/0001193125-26-165158.md) | Proxy statement, period 2026-06-04 | 0001193125-26-165158 |
| 2026-03-16 | 16:06 ET | [8-K](/filings/0001193125-26-108333.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-108333 |
| 2026-03-11 | 07:07 ET | [8-K](/filings/0001193125-26-101073.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-101073 |
| 2026-02-12 | 16:59 ET | [10-K](/filings/0001193125-26-048957.md) | Annual report, period 2025-12-31 | 0001193125-26-048957 |
| 2026-02-12 | 16:35 ET | [8-K](/filings/0001193125-26-048873.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-048873 |
| 2026-01-12 | 08:44 ET | [8-K](/filings/0001193125-26-009880.md) | 8.01 Other events | 0001193125-26-009880 |
| 2025-11-10 | 08:15 ET | [10-Q](/filings/0001193125-25-273337.md) | Quarterly report, period 2025-09-30 | 0001193125-25-273337 |
| 2025-11-10 | 08:10 ET | [8-K](/filings/0001193125-25-273329.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273329 |
| 2025-10-15 | 16:18 ET | [8-K](/filings/0001193125-25-240282.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-240282 |
| 2025-08-04 | 16:30 ET | [10-Q](/filings/0000950170-25-102052.md) | Quarterly report, period 2025-06-30 | 0000950170-25-102052 |
| 2025-08-04 | 16:21 ET | [8-K](/filings/0000950170-25-102027.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102027 |
| 2025-06-26 | 07:08 ET | [8-K](/filings/0000950170-25-090170.md) | 8.01 Other events | 0000950170-25-090170 |
| 2025-06-09 | 16:33 ET | [8-K](/filings/0000950170-25-083799.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-083799 |
| 2025-05-19 | 16:36 ET | [8-K](/filings/0000950170-25-074428.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-074428 |
| 2025-05-06 | 16:10 ET | [10-Q](/filings/0000950170-25-064468.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064468 |
| 2025-05-06 | 16:05 ET | [8-K](/filings/0000950170-25-064435.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064435 |
| 2025-04-16 | 16:05 ET | [DEF 14A](/filings/0000950170-25-054711.md) | Proxy statement, period 2025-06-05 | 0000950170-25-054711 |
| 2025-03-26 | 16:12 ET | [8-K](/filings/0000950170-25-045232.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-045232 |
| 2025-02-11 | 16:10 ET | [10-K](/filings/0000950170-25-017899.md) | Annual report, period 2024-12-31 | 0000950170-25-017899 |
| 2025-02-11 | 16:05 ET | [8-K](/filings/0000950170-25-017879.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-017879 |
| 2024-11-05 | 09:10 ET | [10-Q](/filings/0000950170-24-121105.md) | Quarterly report, period 2024-09-30 | 0000950170-24-121105 |
| 2024-11-05 | 09:05 ET | [8-K](/filings/0000950170-24-121103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121103 |
| 2024-08-05 | 16:10 ET | [10-Q](/filings/0000950170-24-090746.md) | Quarterly report, period 2024-06-30 | 0000950170-24-090746 |
| 2024-08-05 | 16:05 ET | [8-K](/filings/0000950170-24-090727.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-090727 |
| 2024-06-03 | 08:06 ET | [8-K](/filings/0000950170-24-067660.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-067660 |
| 2024-05-23 | 08:14 ET | [8-K](/filings/0000950123-24-005877.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950123-24-005877 |
| 2024-05-08 | 16:20 ET | [10-Q](/filings/0000950170-24-055719.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055719 |
| 2024-05-08 | 16:15 ET | [8-K](/filings/0000950170-24-055689.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055689 |
| 2024-04-09 | 16:42 ET | [DEF 14A](/filings/0000950170-24-043025.md) | Proxy statement, period 2024-05-30 | 0000950170-24-043025 |
| 2024-02-21 | 07:50 ET | [10-K](/filings/0000950170-24-017571.md) | Annual report, period 2023-12-31 | 0000950170-24-017571 |
| 2024-02-21 | 07:45 ET | [8-K](/filings/0000950170-24-017568.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-017568 |
| 2024-02-13 | 17:22 ET | [8-K](/filings/0001193125-24-033973.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-033973 |
| 2024-02-13 | 06:30 ET | [8-K](/filings/0001193125-24-032825.md) | 8.01 Other events | 0001193125-24-032825 |
| 2024-01-16 | 16:11 ET | [8-K](/filings/0000950170-24-004616.md) | 8.01 Other events | 0000950170-24-004616 |
| 2023-12-19 | 16:23 ET | [8-K](/filings/0000950170-23-071505.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-071505 |
| 2023-12-15 | 08:58 ET | [8-K](/filings/0000950170-23-070582.md) | 8.01 Other events | 0000950170-23-070582 |
| 2023-12-13 | 09:22 ET | [8-K](/filings/0000950170-23-069892.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-23-069892 |
| 2023-12-08 | 13:16 ET | [8-K](/filings/0000950170-23-068974.md) | 8.01 Other events | 0000950170-23-068974 |
| 2023-12-04 | 16:26 ET | [8-K](/filings/0000950170-23-067774.md) | 8.01 Other events | 0000950170-23-067774 |
| 2023-11-16 | 07:21 ET | [8-K](/filings/0000950170-23-064341.md) | 8.01 Other events | 0000950170-23-064341 |
| 2023-11-06 | 16:42 ET | [10-Q](/filings/0000950170-23-059476.md) | Quarterly report, period 2023-09-30 | 0000950170-23-059476 |
| 2023-11-06 | 16:33 ET | [8-K](/filings/0000950170-23-059461.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-059461 |
| 2023-09-07 | 08:39 ET | [8-K](/filings/0000950170-23-046889.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-046889 |
| 2023-08-07 | 16:12 ET | [10-Q](/filings/0000950170-23-039075.md) | Quarterly report, period 2023-06-30 | 0000950170-23-039075 |

Page 1 of 5. [Older](/companies/crsp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:32 ET. No prices; not investment advice.